Literature DB >> 18443128

Fitness trade-offs in blaTEM evolution.

Joanna E Mroczkowska1, Miriam Barlow.   

Abstract

bla(TEM-1) expression results in penicillin resistance, whereas expression of many bla(TEM-1) descendants, called extended-spectrum beta-lactamases (ESBLs), results simultaneously in resistance to penicillins and extended-spectrum cephalosporins. Despite the expanded resistance phenotypes conferred by many ESBLs, bla(TEM-1) is still the most abundant bla(TEM) allele in many microbial populations. This study examines the fitness effects of the two amino acid substitutions, R164S and E240K, that have occurred repeatedly among ESBL bla(TEM-1) descendants. Using a single-nucleotide polymorphism-specific real-time quantitative PCR method, we analyzed the fitness of strains expressing bla(TEM-1), bla(TEM-10), and bla(TEM-12). Our results show that bacteria expressing the ancestral bla(TEM-1) allele have a fitness advantage over those expressing either bla(TEM-10) or bla(TEM-12) when exposed to ampicillin. This observation, combined with the fact that penicillins are the most prevalent antimicrobials prescribed worldwide, may explain why bla(TEM-1) has persisted as the most frequently encountered bla(TEM) allele in bacterial populations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18443128      PMCID: PMC2443931          DOI: 10.1128/AAC.00018-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

1.  European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe.

Authors:  Samuel Coenen; Matus Ferech; Katerina Dvorakova; Erik Hendrickx; Carl Suetens; Herman Goossens
Journal:  J Antimicrob Chemother       Date:  2006-05-30       Impact factor: 5.790

2.  Selection and neutrality in lactose operons of Escherichia coli.

Authors:  A M Dean
Journal:  Genetics       Date:  1989-11       Impact factor: 4.562

3.  Penicillinase synthesis controlled by infectious R factors in Enterobacteriaceae.

Authors:  N Datta; P Kontomichalou
Journal:  Nature       Date:  1965-10-16       Impact factor: 49.962

4.  Reversal of clavulanate resistance conferred by a Ser-244 mutant of TEM-1 beta-lactamase as a result of a second mutation (Arg to Ser at position 164) that enhances activity against ceftazidime.

Authors:  U Imtiaz; E K Manavathu; S Mobashery; S A Lerner
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

5.  Resistance of Escherichia coli to penicillins: identification of the structural gene for the chromosomal penicillinase.

Authors:  L G Burman; J T Park; E B Lindström; H G Boman
Journal:  J Bacteriol       Date:  1973-10       Impact factor: 3.490

6.  Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase.

Authors:  D Sirot; J Sirot; R Labia; A Morand; P Courvalin; A Darfeuille-Michaud; R Perroux; R Cluzel
Journal:  J Antimicrob Chemother       Date:  1987-09       Impact factor: 5.790

7.  Infections with nontyphoidal Salmonella species producing TEM-63 or a novel TEM enzyme, TEM-131, in South Africa.

Authors:  Tersia Kruger; Dora Szabo; Karen H Keddy; Kathleen Deeley; Jane W Marsh; Andrea M Hujer; Robert A Bonomo; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

8.  Molecular epidemiology of Enterobacteriaceae isolates producing extended-spectrum beta-lactamases in a French hospital.

Authors:  Jean-Philippe Lavigne; Nicole Bouziges; Catherine Chanal; Aba Mahamat; Sylvie Michaux-Charachon; Albert Sotto
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

9.  Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology.

Authors:  Anne Marie Queenan; Barbara Foleno; Colleen Gownley; Ellyn Wira; Karen Bush
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

10.  The E. coli beta-lactamase attenuator mediates growth rate-dependent regulation.

Authors:  B Jaurin; T Grundström; T Edlund; S Normark
Journal:  Nature       Date:  1981-03-19       Impact factor: 49.962

View more
  15 in total

1.  Evolution of a single gene highlights the complexity underlying molecular descriptions of fitness.

Authors:  Matthew I Peña; Elizabeth Van Itallie; Matthew R Bennett; Yousif Shamoo
Journal:  Chaos       Date:  2010-06       Impact factor: 3.642

2.  Recombination and selection can remove blaTEM alleles from bacterial populations.

Authors:  Joanna E Mroczkowska; Miriam Barlow
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

Review 3.  Beyond horizontal gene transfer: the role of plasmids in bacterial evolution.

Authors:  Jerónimo Rodríguez-Beltrán; Javier DelaFuente; Ricardo León-Sampedro; R Craig MacLean; Álvaro San Millán
Journal:  Nat Rev Microbiol       Date:  2021-01-19       Impact factor: 60.633

4.  Expression of OXA-type and SFO-1 β-lactamases induces changes in peptidoglycan composition and affects bacterial fitness.

Authors:  Ana Fernández; Astrid Pérez; Juan A Ayala; Susana Mallo; Soraya Rumbo-Feal; Maria Tomás; Margarita Poza; Germán Bou
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

Review 5.  Non-phenotypic tests to detect and characterize antibiotic resistance mechanisms in Enterobacteriaceae.

Authors:  Agnese Lupo; Krisztina M Papp-Wallace; Parham Sendi; Robert A Bonomo; Andrea Endimiani
Journal:  Diagn Microbiol Infect Dis       Date:  2013-10-03       Impact factor: 2.803

6.  A design-constraint trade-off underpins the diversity in ecologically important traits in species Escherichia coli.

Authors:  Katherine Phan; Thomas Ferenci
Journal:  ISME J       Date:  2013-05-16       Impact factor: 10.302

7.  Designing antibiotic cycling strategies by determining and understanding local adaptive landscapes.

Authors:  Christiane P Goulart; Mentar Mahmudi; Kristina A Crona; Stephen D Jacobs; Marcelo Kallmann; Barry G Hall; Devin C Greene; Miriam Barlow
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

8.  Rational design of antibiotic treatment plans: a treatment strategy for managing evolution and reversing resistance.

Authors:  Portia M Mira; Kristina Crona; Devin Greene; Juan C Meza; Bernd Sturmfels; Miriam Barlow
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

9.  Antimicrobial resistances do not affect colonization parameters of intestinal E. coli in a small piglet group.

Authors:  Peter Schierack; Kristina Kadlec; Sebastian Guenther; Matthias Filter; Stefan Schwarz; Christa Ewers; Lothar H Wieler
Journal:  Gut Pathog       Date:  2009-10-08       Impact factor: 4.181

Review 10.  Reversibility of antibiotic resistance.

Authors:  Martin Sundqvist
Journal:  Ups J Med Sci       Date:  2014-05       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.